Bold and nimble, Boston Oncology is an innovative biogenerics company redefining excellence in the licensing and local development, manufacturing and distribution of US-quality medicines – across therapeutic areas.
Headquartered in Cambridge, Massachusetts, with principal offices and a world-class manufacturing center in Saudi Arabia, Boston Oncology’s work and our team span continents.
We proceed from the conviction that the quality of a person’s healthcare—and their potential to survive or thrive—should never be determined by wealth, status, or geography.
We leverage our International footprint and close relationships with the world’s leading pharmaceutical innovators to access and license USFDA / EMA registered biogenerics, transfer highly specialized knowledge, and maintain control over dependable supply chains.
Our manufacturing center in Saudi Arabia houses a leading-edge GMP certified facility, with an annual vial capacity of over 30 million units, delivering class-leading quality—quickly, reliably, and at affordable prices in the local market.
